APYX - Apyx Medical Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Apyx Medical Corporation

5115 Ulmerton Road
Clearwater, FL 33760
United States

Sector : Healthcare
Industry : Medical Instruments & Supplies
Full Time Employees : 222

Key Executives

Name Title Pay Exercised Year Born
Mr. Charles D. Goodwin II Pres, CEO & Director 1.49M N/A 1966
Ms. Tara H. Semb CFO, Treasurer & Sec. N/A N/A 1970
Mr. Moshe Citronowicz Sr. VP 588.32k N/A 1953
Mr. Todd Hornsby Exec. VP 504.1k N/A 1976
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates through two segments, Advanced Energy and original equipment manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and the J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Corporate Governance

Apyx Medical Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS) . Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.